Development process of an evidence-based guideline for the treatment of obesity

被引:18
|
作者
Gandjour, A
Westenhöfer, J
Wirth, A
Fuchs, C
Lauterbach, KW
机构
[1] Univ Cologne, Inst Gesundheitsokon & Klin Epidemiol, D-50935 Cologne, Germany
[2] Univ Appl Sci, Fachhsch, Dept Nutr & Home Econ, Hamburg, Germany
[3] Teutoburger Wald Clin, Bad Rothenfelde, Germany
关键词
evidence-based; Germany; guideline; obesity; prevention; therapy;
D O I
10.1093/intqhc/13.4.325
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives. To present the development process, summarize the content and discuss the implications of the German evidence-based guideline for the treatment of obesity. Design. The target audience and the development process were defined by a multidisciplinary team of experts. A systematic search of the literature was performed to identify relevant clinical articles. The validity of published studies was systematically evaluated. After developing the draft, an external peer review process was initiated. Results. Three versions of the guideline were published; an expert version, a short version tailored to primary care physicians and a patient version supporting patient participation in the decision-making process. Total development, printing and distribution costs were estimated to be 300 000 Euro. Conclusions. The guideline raises the awareness of obesity and related comorbidities in Germany and may improve the quality of care for obese patients. The development process could serve as an efficient model for other guideline developers.
引用
收藏
页码:325 / 332
页数:8
相关论文
共 50 条
  • [1] Considered judgement in evidence-based guideline development
    Verkerk, Karin
    Van Veenendaal, Haske
    Severens, Johan L.
    Hendriks, Erik J. M.
    Burgers, Jako S.
    INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2006, 18 (05) : 365 - 369
  • [2] Evidence-based Practice Guideline for the Treatment of CKD
    Clinical and Experimental Nephrology, 2009, 13 : 537 - 566
  • [4] Current Evidence-Based Treatment of Obesity
    Ingersoll, Amy Beth
    NURSING CLINICS OF NORTH AMERICA, 2021, 56 (04) : 495 - 509
  • [5] The value of process measures in evaluating an evidence-based guideline
    Brasel, KJ
    Weigelt, JA
    Christians, KK
    Somberg, LB
    SURGERY, 2003, 134 (04) : 605 - 610
  • [6] Evidence-based guideline: Treatment of parenchymal neurocysticercosis Report of the Guideline Development Subcommittee of the American Academy of Neurology
    Baird, Ruth Ann
    Wiebe, Sam
    Zunt, Joseph R.
    Halperin, John J.
    Gronseth, Gary
    Roos, Karen L.
    NEUROLOGY, 2013, 80 (15) : 1424 - 1429
  • [7] Evidence-based guideline: Treatment of tardive syndromes Report of the Guideline Development Subcommittee of the American Academy of Neurology
    Bhidayasiri, Roongroj
    Fahn, Stanley
    Weiner, William J.
    Gronseth, Gary S.
    Sullivan, Kelly L.
    Zesiewicz, Theresa A.
    NEUROLOGY, 2013, 81 (05) : 463 - 469
  • [8] EVIDENCE-BASED GUIDELINE: TREATMENT OF TARDIVE SYNDROMES: REPORT OF THE GUIDELINE DEVELOPMENT SUBCOMMITTEE OF THE AMERICAN ACADEMY OF NEUROLOGY
    Lerner, Vladimir
    Miodownik, Chanoch
    NEUROLOGY, 2014, 82 (07) : 643 - 643
  • [9] Impact of group structure and process on multidisciplinary evidence-based guideline development: an observational study
    Pagliari, C
    Grimshaw, J
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2002, 8 (02) : 145 - 153
  • [10] The development of a multidisciplinary, evidence-based guideline for "HIV and employment"
    Wagener, Marlies N.
    Roelofs, Pepijn D. D. M.
    Miedema, Harald S.
    Brandjes, Dees P. M.
    Dahmen, Rutger
    van Gorp, Eric C. M.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2015, 27 (02): : 133 - 141